Dissemin is shutting down on January 1st, 2025

Published in

American Association for Cancer Research, Clinical Cancer Research, 6(20), p. 1401-1403, 2014

DOI: 10.1158/1078-0432.ccr-13-3388

Links

Tools

Export citation

Search in Google Scholar

Myeloid Suppressors Decrease Melanoma Survival by Abating Tumor-Fighting T Cells

Journal article published in 2014 by Rolf Kiessling, Yumeng Mao, Yago Pico de Coana ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Upload
Orange circle
Postprint: archiving restricted
Upload
Red circle
Published version: archiving forbidden
Policy details
Data provided by SHERPA/RoMEO

Abstract

Abstract Disseminated malignant melanoma has a poor prognosis. Immunotherapy based on cytokines or checkpoint inhibitors has a protracted beneficial effect in a select group of patients. Understanding the mechanisms that inhibit tumor-specific T cells will help the development of biomarkers to formulate therapy for this disease. Clin Cancer Res; 20(6); 1401–3. ©2014 AACR.